Colorectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For inclusion in the study, patients must fulfill the following requirements preoperatively: (1) histologically proven colorectal carcinoma (2) tumor located in the cecum, ascending colon, sigmoid colon, or rectosigmoid colon (3) T3 or deeper lesion without involvement of other organs (4)without multiple lesion other than carcinoma in situ (5) cancer classified as N0-2 and M0, according to the TNM classification system (6) tumor size 75 years (9) sufficient organ function (10) no history of gastrointestinal surgery (11) no history of chemotherapy or radiotherapy (12) provided written informed consent
Exclusion criteria
Exclusion criteria: Exclusion criteria are as follows: (1) synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ (2) severe pulmonary emphysema, interstitial pneumonitis, or ischemic heart disease (3) pregnant or lactating women (4) severe mental disease (5) continuous systemic steroid therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| relapse-free survival, short-term clinical outcomes, adverse events, the proportion of conversion from LAP to OPEN, the proportion of completion of LAP | — |
Countries
Japan
Contacts
JCOG0404 Coordinating Office Oita University Faculty of Medicine